Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002684.SZ
Valuation Bad
0%
Profitability n.A.
Fin. Growth n.A.
Leverage & Liquidity Bad
0%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamentals

Valuation

Metric Q3 Q1 Δ in %
EV/EBITDA 16.04 -60.78 -72.39
Graham Fair Price -94.36 0.33 5.88
PEG inf 0.00 -0.07
Price/Book -14641.19 -177.61 -1.20
Price/Cash Flow -40.74 34.94 58.96
Prices/Earnings -13.45 -4.82 -4.25
Price/Sales -42.34 9.09 15.76
Price/FCF -40.74 34.94 58.96
Naive Interpretation member
01 - Valuation · Bad
Fundamentals

Profitability

Metric Q3 Q1 Δ in %
Gross Profit Margin -6.02 0.12 0.13
Operating Margin -15.77 -0.32 -0.28
ROA 27.91 -0.03 -0.04
ROE 0.07 9.22 12893.50
ROIC -0.01 -0.02 -58.43
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q3 Q1 Δ in %
Debt QOQ 0.00 < 0.005 inf
Dividends QOQ -0.89 0.00 inf
EBIT QOQ 0.32 0.00 inf
EPS QOQ 0.64 0.00 inf
FCF QOQ 10.31 0.00 inf
Revenue QOQ 0.02 0.00 inf
Naive Interpretation member
03 - Financial Growth · Not Interpreted
Fundamentals

Leverage & Liquidity

Metric Q3 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 208.31 146.47 -29.69
Days Sales Outstanding (DSO) 0.00 0.00 0.00
Inventory Turnover 0.43 0.61 42.22
Debt/Capitalization 13.69 1.01 -92.65
Quick Ratio < 0.005 0.02 186.92
Naive Interpretation member
04 - Leverage & Liquidity · Bad
Fundamentals

Per Share Metrics

Metric Q3 Q1 Δ in %
Book Value -4.66 -0.02 99.51
Cash 0.09 0.18 113.39
Capex -0.02 < 0.005 62.70
Free Cash Flow 0.10 0.12 23.03
Revenue 0.36 0.45 26.44
Naive Interpretation member
05 - Per Share Metrics · Best
Fundamentals

Financial Health

Metric Q3 Q1 Δ in %
Current Ratio 0.37 0.40 7.20
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -33.89 -29.56 12.78
Naive Interpretation Member
06 - Financial Health · Bad